1.
Vox Sang
; 102(3): 272, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21957873
2.
Vox Sang
; 100(3): 340-2, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21392024
RESUMO
BACKGROUND AND OBJECTIVE: The risk of hepatitis E virus (HEV) to blood safety remains unknown in England. Reports of persistent HEV infection with serious disease sequelae indicate that transfusion transmitted HEV is not a trivial disease in immunosuppressed patients. MATERIALS AND METHODS: Samples from unselected blood donors and donors with a history of jaundice were tested for HEV antibody and RNA. RESULTS: Overall, 10% of the donor sera were anti-HEV IgG reactive. Four of the donor samples were anti-HEV IgM reactive but HEV RNA negative. CONCLUSION: There is evidence of probable recent HEV infections in donors with a predicted attack rate of 2.8%.